Dr. Andrew S. Kennedy

Claim this profile

Henrico Doctor's Hospital

Studies Breast Cancer
Studies Recurrence
5 reported clinical trials
24 drugs studied

Area of expertise

1Breast Cancer
Andrew S. Kennedy has run 1 trial for Breast Cancer. Some of their research focus areas include:
ER positive
PR positive
HER2 negative
2Recurrence
Andrew S. Kennedy has run 1 trial for Recurrence. Some of their research focus areas include:
ER positive
PR positive
HER2 negative

Affiliated Hospitals

Image of trial facility.
Henrico Doctors Hospital
Image of trial facility.
Mission Hospital

Clinical Trials Andrew S. Kennedy is currently running

Image of trial facility.

Surgery and Radiation vs. Radiation Alone

for Brain Cancer

This phase III trial compares the addition of stereotactic radiosurgery before or after surgery in treating patients with cancer that has spread to the brain (brain metastases). Stereotactic radiosurgery is a type of radiation therapy that delivers a high dose of radiation only to the small areas of cancer in the brain and avoids the surrounding normal brain tissue. Surgery and radiation may stop the tumor from growing for a few months or longer and may reduce symptoms of brain metastases.
Recruiting2 awards Phase 3
Image of trial facility.

Herceptin Hylecta or Phesgo + Chemotherapy

for Uterine Cancer

This phase II/III trial tests whether adding trastuzumab and hyaluronidase-oysk (Herceptin HylectaTM) or pertuzumab, trastuzumab and hyaluronidase-zzxf (PhesgoTM) to the usual chemotherapy (paclitaxel and carboplatin) works to shrink tumors in patients with HER2 positive endometrial serous carcinoma or carcinosarcoma. Trastuzumab and pertuzumab are monoclonal antibodies and forms of targeted therapy that attach to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When trastuzumab or pertuzumab attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Hyaluronidase is an endoglycosidase. It helps to keep pertuzumab and trastuzumab in the body longer, so that these medications will have a greater effect. Hyaluronidase also allows trastuzumab and trastuzumab/pertuzumab to be given by injection under the skin and shortens their administration time compared to trastuzumab or pertuzumab alone. Paclitaxel is a taxane and in a class of medications called antimicrotubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Giving Herceptin Hylecta or Phesgo in combination with paclitaxel and carboplatin may shrink the tumor and prevent the cancer from coming back in patients with HER2 positive endometrial serous carcinoma or carcinosarcoma.
Recruiting1 award Phase 2 & 3

More about Andrew S. Kennedy

Clinical Trial Related2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Andrew S. Kennedy has experience with
  • Radiation
  • Tamoxifen
  • Anastrozol
  • Letrozole
  • Exemestane
  • Degarelix

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew S. Kennedy specialize in?
Andrew S. Kennedy focuses on Breast Cancer and Recurrence. In particular, much of their work with Breast Cancer has involved ER positive patients, or patients who are PR positive.
Is Andrew S. Kennedy currently recruiting for clinical trials?
Yes, Andrew S. Kennedy is currently recruiting for 5 clinical trials in Richmond Virginia. If you're interested in participating, you should apply.
Are there any treatments that Andrew S. Kennedy has studied deeply?
Yes, Andrew S. Kennedy has studied treatments such as Radiation, Tamoxifen, Anastrozol.
What is the best way to schedule an appointment with Andrew S. Kennedy?
Apply for one of the trials that Andrew S. Kennedy is conducting.
What is the office address of Andrew S. Kennedy?
The office of Andrew S. Kennedy is located at: Henrico Doctor's Hospital, Richmond, Virginia 23229 United States. This is the address for their practice at the Henrico Doctor's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.